Bone densitometry is an essential tool for the diagnosis of osteoporosis, for fracture prediction, and for treatment monitoring. However, the multitude of modalities, techniques, and implementations is confusing for the clinician who needs support in making clinical decisions. Obviously, this requires clear definitions of quantities and units, and standardization of acquisition and analysis routines. On the other hand, it has to be understood that bone is not a simple entity that can be characterized by just two or three measures for which thresholds can be defined according to which a patient is osteoporotic or not or should be treated or not.
standardization approaches have been implemented resulting in standardized BMD a values. This is a major disadvantage of bone densitometry because, despite the standardization efforts, it is still not advisable to change between scanners of different manufacturers in serial measurements.
With respect to ultrasound, the situation is even more complex. Broadband ultrasound attenuation and speed of sound are the two basic measurable quantities, but as discussed in Section 7.2.1.6, there is a variety of different wave types that all have their own SOS. It would be advisable to assign wave type characteristic subscripts to SOS, but such an attempt has not been made partly because it is very difficult to distinguish different wave type contributions in the received signal. Inability to suggest a clear nomenclature is currently a shortcoming of the present Report and for the field in general. For a standardization of ultrasound devices, a standardization of wave excitation, signal analysis, and reference data would be required, none of which has been implemented so far and, therefore, numerical results from different devices are less comparable than for x-ray techniques.
From a clinical perspective, a comparison of the diagnostic potential across different techniques and modalities is required. Here, the concept of standardized performance measures as discussed in Section 3 is available. DXA of the lumbar spine in PA projection should be used as reference technique, because for this technique the most comprehensive variety of data is available and because implementations for this technique vary less than for other techniques.
Finally, it must be pointed out again that the ultimate clinical goal is fracture prevention. Intermediate goals are the accurate determination of fracture risk and the differentiation of its underlying causes. However, in bone densitometry surrogate measures more or less highly correlated with or predictive of fracture risk are determined. For many years, BMD a has been and still is the most frequently used measure, but fracture prediction based on BMD a is still not adequate for individual treatment decisions. This dilemma has sparked continued interest in other measures assessable in vivo to improve the diagnostic potential and predictive power of bone mineral density measurements. As described in the present Report, today a large and growing variety of x-ray-and ultrasoundbased measures exist, most of which are highly correlated with BMD a . Most active research is carried out in QCT to measure BMD and bone geometry and in QUS to exploit the dependence of the ultrasound signal on material or micro-structural properties other than density.
So far, no recommendation can be given as to which variable(s) instead or in addition to BMD a should be used for fracture prediction or treatment decisions. One reason is that standardized performance measures, in particular for new parameters, often do not exist. Another reason, in particular, with respect to ultrasound attenuation, is that the underlying physical theory still is not fully understood. And a third reason is that even on a microscopic scale, fracture mechanisms and their underlying causes are also currently not fully understood. It is likely that a single skeletal measure will always be insufficient to reflect bone fragility since bone strength is not a scalar measure and it depends on the loading conditions; as a consequence, we cannot expect to find a single measure. However, a larger set of parameters that in combination would accurately predict who will eventually fracture does also not exist. This remains true when including additional factors such as genetics or life style.
Obviously, the problem of accurate determination of fracture risk and differentiation of its underlying causes cannot be attributed to the field of bone densitometry. The diagnostic problem would continue to exist even if bone structure at the spine and hip could be measured in vivo. It remains the task of the physician to be aware of the limitations of bone densitometry and to use its probably still increasing potential appropriately. It is hoped that the present Report will nevertheless provide the necessary guidance and will help to develop and to consolidate the field of bone densitometry further.
